|
FDA approves GSK asthma medicine
Philadelphia Business Journal (blog) The product, Arnuity Ellipta, is an inhaled corticosteroid medicine designed to be taken a once-daily by asthma patients 12 years of age and older. Asthma is a chronic lung disease that inflames and narrows the airways. An estimated 26 million people … GlaxoSmithKline plc (GSK) Receives FDA Approval of Arnuity Ellipta as Asthma … GSK Gets FDA Approval For Asthma Drug Arnuity Ellipta |
View full post on asthma – Google News